Noventia Pharma is a speciality pharmaceutical Company based in Milano, Italy. Founded in 2009 and with operations in Southern Europe, Noventia’s focus is the research, development, and marketing of Orphan Drugs.
Massimo Radaelli is the Founder, President and CEO of Noventia Pharma, and also the CEO and Board Member of Napo Therapeutics. Both companies have Rare Diseases as their primary focus.
The European is the definitive voice of global business, available in print, online and at the world’s key trade events. With expert coverage of finance, ESG, technology, energy, leadership and emerging market trends, it delivers sharp insight, analysis and thought leadership that shape boardroom decisions and influence strategy worldwide. Our agenda-setting journalism is syndicated to leading media outlets worldwide through the European Digital Content Exchange Network – the first and only initiative of its kind in Europe – extending our influence and reinforcing The European’s position as a trusted source of high-quality global business insight.
CP Media Global Limited
77 Marsh Wall
Canary Wharf
London
E14 9SH
This website and all of the contents are property of CP Media Global Limited. Images, content and any other material may not be copied or reproduced without first obtaining written permission from CP Media Global Limited.
Receive every edition of the European, along with supplements, directly into your email inbox upon release.
Receive every edition of the European, along with supplements, directly into your email inbox upon release.
Please complete the payment process in order to receive all 4 issues of The European Magazine directly to your door As soon as payment is processed, the current edition will be dispatch to your postal address.
Annual Quarterly Subscription (4 Issues) Shipping Options